Medical Device Securement System

Abstract

A securement device for securing medical devices. The securement device includes a body member and is configured to conform to a patient when adhered to the patient. The body member can include a first surface and a second surface opposite the first surface, the first surface including an adhesive thereon. One or more pads can be positioned on the first surface of the body member, and a channel can be included in at least one pad of the one or more pads, between at least two pads of the one or more pads, or formed when a medical device is pressed into the one or more pads. The securement device can mitigate lateral and longitudinal motion of the medical device when the medical device is disposed in the channel.

What is claimed is: 
     
         1 . A securement device for securing medical devices, comprising:
 a body member including a first surface and a second surface opposite the first surface, the first surface including an adhesive thereon;   one or more pads on the first surface of the body member; and   a channel in at least one pad of the one or more pads, between at least two pads of the one or more pads, or formed when a medical device is pressed into the one or more pads,   wherein the securement system is configured to conform to a patient when adhered to the patient and mitigate lateral and longitudinal motion of the medical device when the medical device is disposed in the channel.   
     
     
         2 . The securement device according to  claim 1 , wherein each pad of the one or more pads is formed of an organopolysiloxane composition. 
     
     
         3 . The securement device according to  claim 2 , wherein the organopolysiloxane of the organopolysiloxane composition is of formula I 
       
         
           
           
               
               
           
         
         where R is a monovalent hydrocarbon radical, R 1  is selected from alkyl, alkenyl, and aryl radicals, R 2  is selected from alkyl and aryl radicals, R 4  and R 5  are independently selected from alkyl and vinyl radicals, x varies from 0-3000, and y varies from 0-300, 
         wherein at least one of R or R 1  includes the alkenyl radical or at least one of R 4  or R 5  includes the vinyl radical, and 
         wherein about 30-90% of the alkenyl radicals or vinyl radicals are crosslinked in the organopolysiloxane composition. 
       
     
     
         4 . The securement device according to  claim 2 , wherein the organopolysiloxane of the organopolysiloxane composition is of formula II 
       
         
           
           
               
               
           
         
         where R is a monovalent hydrocarbon radical, R 1  and R 6  are independently selected from alkyl, alkenyl, and aryl radicals, R 2  is a monovalent hydrocarbon radical, R 3  is selected from alkyl, alkenyl, and aryl radicals, w varies from 0-500, and z varies from 0-200, 
         wherein at least one of R, R 1 , R 2 , or R 3  includes the alkenyl radical, and 
         wherein about 30-90% of the alkenyl radicals are crosslinked in the organopolysiloxane composition. 
       
     
     
         5 . The securement device according to  claim 2 , wherein the organopolysiloxane composition includes polydimethylsiloxane or poly(methyl hydrogen siloxane). 
     
     
         6 . The securement device according to  claim 2 , wherein the organopolysiloxane composition includes a reinforcing agent selected from titanium dioxide, calcium carbonate, lithopone, zinc oxide, zirconium silicate, silica aerogel, iron oxide, diatomaceous earth, silazane-treated silica, precipitated silica, fumed silica, mined silica, glass fibers, magnesium oxide, chromic oxide, zirconium oxide, aluminum oxide, alpha quartz, and calcined clay. 
     
     
         7 . The securement device according to  claim 6 , wherein the reinforcing agent is about 10-30% by weight of the organopolysiloxane composition. 
     
     
         8 . The securement device according to  claim 2 , wherein the organopolysiloxane composition has a tackiness of about 10-450 g as determined by a probe tack tester. 
     
     
         9 . The securement device according to  claim 2 , wherein the organopolysiloxane composition has a hardness of about 5-55 units (Shore OO). 
     
     
         10 . The securement device according to  claim 2 , wherein the organopolysiloxane composition has a tensile strength of about 20-800 psi. 
     
     
         11 . The securement device according to  claim 2 , wherein the organopolysiloxane composition has a tear strength of about 5-200 lbs/in. 
     
     
         12 . The securement device according to  claim 2 , wherein the organopolysiloxane composition has a minimum elongation of about 250-1100%. 
     
     
         13 . A securement device for securing medical devices, comprising:
 a body member including a first surface and a second surface opposite the first surface, the first surface including an adhesive thereon configured to adhere the body member to skin of a patient;   one or more pads on the first surface of the body member formed of an organopolysiloxane composition, the organopolysiloxane of the organopolysiloxane composition of formula I   
       
         
           
           
               
               
           
         
         
           where R is a monovalent hydrocarbon radical, R 1  is selected from alkyl, alkenyl, and aryl radicals, R 2  is selected from alkyl and aryl radicals, R 4  and R 5  are independently selected from alkyl and vinyl radicals, x varies from 0-3000, and y varies from 0-300, 
           where at least one of R or R 1  includes the alkenyl radical or at least one of R 4  or R 5  includes the vinyl and about 30-60% of the alkenyl radicals or vinyl radicals are crosslinked in the organopolysiloxane composition; and 
         
         a channel in at least one pad of the one or more pads, between at least two pads of the one or more pads, or formed when a medical device is pressed into the one or more pads, 
         wherein the securement system is configured to conform to a patient when adhered to the patient and mitigate lateral and longitudinal motion of the medical device when the medical device is disposed in the channel. 
       
     
     
         14 . The securement device according to  claim 13 , wherein the organopolysiloxane composition includes about 10-30% by weight of a reinforcing agent selected from titanium dioxide, calcium carbonate, lithopone, zinc oxide, zirconium silicate, silica aerogel, iron oxide, diatomaceous earth, silazane-treated silica, precipitated silica, fumed silica, mined silica, glass fibers, magnesium oxide, chromic oxide, zirconium oxide, aluminum oxide, alpha quartz, and calcined clay. 
     
     
         15 . The securement device according to  claim 13 , wherein the organopolysiloxane composition includes polydimethylsiloxane or poly(methyl hydrogen siloxane). 
     
     
         16 . The securement device according to  claim 13 , wherein the organopolysiloxane composition has a tackiness of about 10-450 g as determined by a probe tack tester, a hardness of about 5-55 units (Shore OO), a tensile strength of about 20-800 psi, a tear strength of about 5-200 lbs/in, and a mini mum elongation of ab out 250-1100%. 
     
     
         17 . A securement device for securing medical devices, comprising:
 a body member including a first surface and a second surface opposite the first surface, the first surface including an adhesive thereon configured to adhere the body member to skin of a patient;   one or more pads on the first surface of the body member formed of an organopolysiloxane composition, the organopolysiloxane of the organopolysiloxane composition of formula II   
       
         
           
           
               
               
           
         
         
           where R is a monovalent hydrocarbon radical, R 1  and R 6  are independently selected from alkyl, alkenyl, and aryl radicals, R 2  is a monovalent hydrocarbon radical, R 3  is selected from alkyl, alkenyl, and aryl radicals, w varies from 0-500, and z varies from 0-200, and 
           where at least one of R, R 1 , R 2 , or R 3  includes the alkenyl radical and about 30-60% of the alkenyl radicals are crosslinked in the organopolysiloxane composition; and 
         
         a channel in at least one pad of the one or more pads, between at least two pads of the one or more pads, or formed when a medical device is pressed into the one or more pads, 
         wherein the securement system is configured to conform to a patient when adhered to the patient and mitigate lateral and longitudinal motion of the medical device when the medical device is disposed in the channel. 
       
     
     
         18 . The securement device according to  claim 17 , wherein the organopolysiloxane composition includes about 10-30% by weight of a reinforcing agent selected from titanium dioxide, calcium carbonate, lithopone, zinc oxide, zirconium silicate, silica aerogel, iron oxide, diatomaceous earth, silazane-treated silica, precipitated silica, fumed silica, mined silica, glass fibers, magnesium oxide, chromic oxide, zirconium oxide, aluminum oxide, alpha quartz, and calcined clay. 
     
     
         19 . The securement device according to  claim 17 , wherein the organopolysiloxane composition includes polydimethylsiloxane or poly(methyl hydrogen siloxane). 
     
     
         20 . The securement device according to  claim 17 , wherein the organopolysiloxane composition has a tackiness of about 10-450 g as determined by a probe tack tester, a hardness of about 5-55 units (Shore OO), a tensile strength of about 20-800 psi, a tear strength of about 5-200 lbs/in, and a minimum elongation of about 250-1100%.